Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
A National Cancer Institute–sponsored clinical trial is conducting comprehensive omics analyses of pediatric and adult solid tumors and esta…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 [Phase 2]
An ongoing Phase 2 trial evaluating the WEE1 inhibitor adavosertib (AZD1775) in advanced solid tumors with SETD2 mutations, including clear …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma [Phase 1, Phase 2]
Orellanine is being studied in metastatic renal cell carcinoma (clear-cell and papillary) in Phase 1/Phase 2, with patient recruitment curre…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) [Phase 3]
Phase 3 trial LS-034 evaluating belzutifan (MK-6482) in combination with zanzalintinib for renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) [Phase 3]
Extension study update for participants in Phase 3 trials of Belzutifan (MK-6482-043 / LITESPARK-043) with ongoing recruitment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers [Phase 1]
Phase 1 clinical trial update evaluating DS3201 in combination with ipilimumab for metastatic prostate, urothelial, and renal cell cancers.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Use of Tracking Devices to Locate Abnormalities During Invasive Procedures [NA]
NIH-sponsored clinical trial update describes a study evaluating tracking devices to locate abnormalities during invasive procedures, with e…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
AstraZeneca is conducting a Phase 1/2 trial to evaluate the safety of AZD6750 in adults with select advanced or metastatic solid tumors; the…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Multimodal Machine Learning Characterization of Solid Tumors
This ClinicalTrials.gov update describes a multimodal machine learning study to characterize solid tumors, listing prostate cancer, hepatoce…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC) [Phase 2]
Phase II trial evaluating evolocumab plus nivolumab to bolster immunotherapy in metastatic renal cell carcinoma. The study is active but not…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of DCC-2812 in Participants With Advanced Genitourinary Cancers [Phase 1]
This clinical trial update reports that a Phase 1 study of DCC-2812 in advanced genitourinary cancers (renal cell carcinoma, urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Bevacizumab, Erlotinib, and Atezolizumab for advanced renal cell carcinoma. The study i…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Ongoing ClinicalTrials.gov study investigating the genetic causes and cancer predisposition in hereditary leiomyomatosis with renal cell car…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer [Phase 1, Phase 2]
Pfizer is conducting a Phase 1/2 study of PF-08634404 in adults with locally advanced or metastatic renal cell carcinoma; the trial is curre…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAIX PET/ CT Guided Radiation Therapy in CcRCC. [NA]
This entry reports an ongoing clinical trial evaluating CAIX PET/CT-guided radiation therapy for clear cell renal cell carcinoma, including …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
This clinical trial analyzes genetics of Birt-Hogg-Dubé syndrome and its link to kidney cancer. It is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) [Phase 3]
Phase 3 trial evaluating belzutifan and zanzalintinib in people with recurrent renal cell carcinoma after adjuvant therapy; the study is cur…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of thermal ablation and spine stereotactic radiosurgery for spine metasta…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 clinical trial evaluating nivolumab and ipilimumab with and without Camu Camu in metastatic renal cell carcinoma, including clear ce…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Validation of RCC Predicting Model With Emulated-target Trial
This clinical trial update describes validation of a renal cell carcinoma prognostic model using an emulated-target trial approach, currentl…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]
This update notes a Phase 2 clinical trial investigating the combination of tivozanib and nivolumab in advanced non-clear cell renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…